| COVID-19 and Mental Health | Lifetime | 59 | IN 1 | 99.17 |
| Intensive Care Unit Cognitive Disorders | Lifetime | 139 | IN 1 | 99.05 |
| Anesthesia and Sedative Agents | Lifetime | 151 | IN 1 | 98.92 |
| Family Caregiving in Mental Illness | Lifetime | 31 | IN 1 | 98.88 |
| Mental Health Treatment and Access | Lifetime | 168 | IN 1 | 99.10 |
| Health and Well-being Studies | Lifetime | 109 | IN 1 | 97.83 |
| Anesthesia and Neurotoxicity Research | Lifetime | 237 | IN 2 | 98.25 |
| Schizophrenia research and treatment | Lifetime | 297 | IN 1 | 98.92 |
| Sexual function and dysfunction studies | Lifetime | 134 | IN 4 | 98.25 |
| Long-Term Effects of COVID-19 | Lifetime | 417 | IN 5 | 96.80 |
| Psychosomatic Disorders and Their Treatments | Lifetime | 218 | IN 1 | 98.23 |
| Electroconvulsive Therapy Studies | Lifetime | 90 | IN 1 | 98.49 |
| Bipolar Disorder and Treatment | Lifetime | 270 | IN 1 | 98.38 |
| Mental Health and Psychiatry | Lifetime | 230 | IN 1 | 98.20 |
| COVID-19 Pandemic Impacts | Lifetime | 174 | IN 10 | 95.78 |
| Treatment of Major Depression | Lifetime | 277 | IN 2 | 97.88 |
| Healthcare professionals’ stress and burnout | Lifetime | 302 | IN 1 | 96.65 |
| Takotsubo Cardiomyopathy and Associated Phenomena | Lifetime | 66 | IN 1 | 96.22 |
| Healthcare Decision-Making and Restraints | Lifetime | 184 | IN 1 | 96.07 |
| Religion, Spirituality, and Psychology | Lifetime | 282 | IN 1 | 95.61 |
| Alcoholism and Thiamine Deficiency | Lifetime | 212 | IN 1 | 94.80 |
| Maternal Mental Health During Pregnancy and Postpartum | Lifetime | 814 | IN 3 | 95.66 |
| Obsessive-Compulsive Spectrum Disorders | Lifetime | 448 | IN 2 | 96.10 |
| Chronic Disease Management Strategies | Lifetime | 931 | IN 9 | 95.13 |
| Body Image and Dysmorphia Studies | Lifetime | 256 | IN 2 | 94.79 |
| Psychiatric care and mental health services | Lifetime | 685 | IN 3 | 91.96 |
| Sexuality, Behavior, and Technology | Lifetime | 748 | IN 1 | 92.18 |
| Medical Education and Admissions | Lifetime | 721 | IN 4 | 86.38 |
| Perfectionism, Procrastination, Anxiety Studies | Lifetime | 538 | IN 4 | 86.68 |
| Menopause: Health Impacts and Treatments | Lifetime | 967 | IN 3 | 86.55 |
| Parkinson's Disease and Spinal Disorders | Lifetime | 748 | IN 10 | 74.26 |
| Hallucinations in medical conditions | Lifetime | 388 | IN 8 | 58.33 |
| COVID-19 and Mental Health | 2021-2025 | 230 | IN 4 | 97.45 |
| Schizophrenia research and treatment | 2021-2025 | 63 | IN 1 | 98.27 |
| Electroconvulsive Therapy Studies | 2021-2025 | 12 | IN 1 | 97.43 |
| Family Caregiving in Mental Illness | 2021-2025 | 16 | IN 1 | 95.35 |
| Bipolar Disorder and Treatment | 2021-2025 | 72 | IN 1 | 97.06 |
| Mental Health Treatment and Access | 2021-2025 | 144 | IN 4 | 96.41 |
| Intensive Care Unit Cognitive Disorders | 2021-2025 | 356 | IN 1 | 94.22 |
| Health, psychology, and well-being | 2021-2025 | 77 | IN 1 | 91.27 |
| Child and Adolescent Psychosocial and Emotional Development | 2021-2025 | 547 | IN 1 | 94.59 |
| Treatment of Major Depression | 2021-2025 | 137 | IN 1 | 94.05 |
| Anesthesia and Sedative Agents | 2021-2025 | 226 | IN 1 | 90.57 |
| Mental Health and Psychiatry | 2021-2025 | 137 | IN 1 | 91.68 |
| Fibromyalgia and Chronic Fatigue Syndrome Research | 2021-2025 | 611 | IN 3 | 83.28 |
| Suicide and Self-Harm Studies | 2021-2025 | 802 | IN 8 | 85.10 |
| Obsessive-Compulsive Spectrum Disorders | 2021-2025 | 451 | IN 4 | 83.88 |
| Anesthesia and Neurotoxicity Research | 2021-2025 | 676 | IN 8 | 76.51 |
| Sexual function and dysfunction studies | 2021-2025 | 785 | IN 9 | 76.17 |
| Body Image and Dysmorphia Studies | 2021-2025 | 699 | IN 7 | 59.96 |
| Restless Legs Syndrome Research | 2021-2025 | 787 | IN 13 | 46.91 |
| Takotsubo Cardiomyopathy and Associated Phenomena | 2021-2025 | 715 | IN 6 | 45.61 |
